Nevirapine (NVP) Concentrations in HIV-Infected Newborns Receiving Therapeutic Dosing
Very early antiretroviral treatment (ART) initiation in HIV infected newborns may limit the seeding of viral reservoirs and maintain immune responses, but few antiretroviral agents are approved for use in newborns. Prophylactic NVP dosing is well established, but the appropriate NVP dose for treatment, which requires higher NVP levels than prophylaxis, is still unknown. While…